NCT07304752 Effect of Probe Material on Peri-implant Probing
| NCT ID | NCT07304752 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Barcelona |
| Condition | Peri-implant Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2026-01-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate whether the type of probe (plastic vs. metallic) modifies the accuracy of peri-implant probing in single-unit implants, by comparing the probing depth recorded with the prosthesis in place versus without the prosthesis (ΔPD, mm). Secondarily, explore the influence of prosthetic design and implant position on probing values and on other clinical and radiographic parameters.
Eligibility Criteria
Inclusion Criteria: * Adults (≥18 years) * Presence of at least one single-unit bone-level implant rehabilitated with a screw-retained prosthesis directly connected to the implant (no intermediate abutment) * Implant in function for at least 1 year after prosthetic loading * No pathological bone loss on periapical radiograph (distance from the most coronal rough surface of the implant to the bone crest \< 3 mm) * Ability to understand and sign informed consent * Peri-implant health or mucositis, defined according to the 2017 World Workshop criteria: * Health: no clinical signs of inflammation, lack of profuse (line or drop) bleeding on probing, no increase in probing depth compared to previous records, and no progressive bone loss beyond initial remodeling (\<2 mm). In the absence of previous radiographs, radiographic bone level \<3 mm without bleeding and/or suppuration on probing. * Mucositis: presence of bleeding and/or suppuration on probing, no increase in probing depth compared to previous records, and no bone loss beyond initial remodeling (\<2 mm). In the absence of previous radiographs, radiographic bone level \<3 mm with bleeding and/or suppuration on probing. Exclusion Criteria: * Cement-retained restorations or prostheses that cannot be removed * Systemic antibiotic or anti-inflammatory treatment within the previous 3 months * Pregnancy or lactation * Peri-implant treatment within the previous 3 months * Participation in another clinical trial within the last 30 days
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07304752 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peri-implant Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07304752 currently recruiting?
Yes, NCT07304752 is actively recruiting participants. Contact the research team at ocamps@ub.edu for enrollment information.
Where is the NCT07304752 trial being conducted?
This trial is being conducted at L'Hospitalet de Llobregat, Spain.
Who is sponsoring the NCT07304752 clinical trial?
NCT07304752 is sponsored by University of Barcelona. The trial plans to enroll 64 participants.